|
|
Line 51: |
Line 51: |
| <!-- end #content-header --> | | <!-- end #content-header --> |
| | | |
- | <div id="page">
| + | <div id="page"> |
| <div id="content_normal"> | | <div id="content_normal"> |
| <div class="post"> | | <div class="post"> |
- | <div id="gototop"><a href="#"><img src="https://static.igem.org/mediawiki/2014/5/55/Tokyo_Tech_Go-to-top-icon.png" height="50" /></a></div>
| |
| <h2 class="title"><a href="https://2014.igem.org/Team:Tokyo_Tech/Policy_and_Practice">Parts</a></h2> | | <h2 class="title"><a href="https://2014.igem.org/Team:Tokyo_Tech/Policy_and_Practice">Parts</a></h2> |
- | <span class="meta">Each parts give us a whole new experience </span> | + | |
| + | <span class="meta">Each part give us a whole new experience </span> |
| <div class="entry-long"> | | <div class="entry-long"> |
| <h3> </h3> | | <h3> </h3> |
- | <span class="head">Favorite Tokyo Tech 2014 iGEM Team Parts</span><br /> | + | <h2>Favorite Tokyo Tech 2014 iGEM Team Parts |
- | <br />
| + | <br /> |
- | <br /> | + | </h2> |
| <div align="center"><table width="799" border="1"> | | <div align="center"><table width="799" border="1"> |
| <tr bgcolor="#DFDFDF"> | | <tr bgcolor="#DFDFDF"> |
Line 96: |
Line 96: |
| </tr> | | </tr> |
| </table> | | </table> |
- | <br /> | + | <p> </p> |
| </div> | | </div> |
- | <p><span class="head">Tokyo Tech 2013 iGEM Team Parts</span></p> | + | <h2>Tokyo Tech 2013 iGEM Team Parts</h2> |
| <div align="center"> | | <div align="center"> |
| <table width="799" border="1"> | | <table width="799" border="1"> |
Line 150: |
Line 150: |
| </tr> | | </tr> |
| </table> | | </table> |
- | <br /> | + | <p> </p> |
| </div> | | </div> |
| <table width="900" border="0"> | | <table width="900" border="0"> |
| <tr> | | <tr> |
- | <td colspan="2"><span class="head">Best new BioBrick part (natural and engineered): <a href="http://parts.igem.org/Part:BBa_K1139021" rel="nofollow">BBa_K</a></span></td> | + | <td colspan="2"><h2>Best new Basic part<span class="head">: <a href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a>, <a href="http://parts.igem.org/Part:BBa_K1529310">BBa_K1529310</a>, <a href="http://parts.igem.org/Part:BBa_K1529320">BBa_K1529320</a></span></h2></td> |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td width="561"> </td>
| + | |
- | <td width="329"> </td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td>Informations</td> | + | <td width="561"><p class="head">• Prhl(RL) : <a href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a> <br /> |
- | <td><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></td>
| + | • Prhl(LR) : <a href="http://parts.igem.org/Part:BBa_K1529310">BBa_K1529310</a> <br /> |
- | </tr>
| + | • Prhl(RR) : <a href="http://parts.igem.org/Part:BBa_K1529320">BBa_K1529320</a> </p> |
- | <tr>
| + | <p align="justify" class="info-18">Prhl(RL) Promoter has the biggest ratio of leakage and expression (when C4HSL is induced) among the three above.</p> </td> |
- | <td> </td>
| + | <td width="329"><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></td> |
- | <td> </td> | + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 175: |
Line 170: |
| <table width="900" border="0"> | | <table width="900" border="0"> |
| <tr> | | <tr> |
- | <td colspan="2" class="head">Best new BioBrick part (natural): <a href="http://parts.igem.org/Part:BBa_K1139020" rel="nofollow">BBa_K</a></td> | + | <td colspan="2"><h2>Best new Composite part<span class="head">: <a href="http://parts.igem.org/Part:BBa_K1529301">BBa_K1529301</a>, <a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a><a href="http://parts.igem.org/Part:BBa_K1139020" rel="nofollow"></a></span></h2></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td width="445"> </td> | + | <td colspan="2"><p class="head">Prhl(RL)_GFP (<a href="http://parts.igem.org/Part:BBa_K1529301">BBa_K1529301</a>)</p></td> |
- | <td width="445"> </td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2">Informations</td> | + | <td colspan="2"><p align="justify" class="info-18">Prhl(RL) is a promoter that is activated by C4HSL. |
| + | We improved Prhl Promoter(<a href="http://parts.igem.org/wiki/index.php/Part:BBa_R0071">BBa_R0071</a>) by changing LuxR binding site of Plux Promoter(<a href="http://parts.igem.org/wiki/index.php/Part:BBa_R0062">BBa_R0062</a>) to RhlR binding site. |
| + | To characterize the function of the Prhl(RL) Promoter (<a href="http://parts.igem.org/wiki/index.php/Part:BBa_K1529300">BBa_K1529300</a>), we constructed this part, Prhl(RL)_GFP (<a href="http://parts.igem.org/wiki/index.php/Part:BBa_K1529301">BBa_K1529301</a>) , by inserting a Prhl(RL) promoter into the upstream region of GFP coding sequence. By using reporter cells containing Prhl(RL)_GFP, we measured the fluorescence intensity of the cells induced by C4HSL. We confirmed that our new Prhl(RL) promoter was actually activated by C4HSL through an induction assay (Fig. 5-1-1).</p> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td> | + | <td colspan="2"><div align="center"></div> <div align="center"><img src="" height="400" /></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></div></td> | + | <td colspan="2"><div align="center"> Fig. 5-1-1. Prhl(RL) has no leakage and higher expression</div> <div align="center"></div></td> |
- | <td><div align="center"><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></div></td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><div align="center"></div></td> | + | <td width="445"> </td> |
- | <td><div align="center"></div></td> | + | <td width="445"> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td> </td> | + | <td colspan="2"><p class="head">Prhl(RL)_CmR_LasI (<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>)</p></td> |
- | <td> </td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><span class="head">Best improved part and Best new BioBrick part (natural): <a href="http://parts.igem.org/Part:BBa_K1139201" rel="nofollow">BBa_K</a></span> </td> | + | <td colspan="2"><p align="justify" class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a>, <a href="http://parts.igem.org/Part:BBa_K395160">BBa_K395160</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0078">BBa_C0078</a>. <br /> |
| + | (CmR is Chloramphenicol resistance.) |
| + | </p> |
| + | <p align="justify" class="info-18">Prhl(RL) Promoter has no leakage and higher expression than Prhl Promoter (<a href="http://parts.igem.org/wiki/index.php/Part:BBa_R0071">BBa_R0071</a>). CmR and LasI are inserted into the downstream of the promoter. |
| + | This is the first Biobrick part that succeeded in C4HSL dependent CmR and 3OC12HSL production. Using this part with the plasmid that is constitutively expressing RhlR, we succeeded in confirming RhlR activates the expression of CmR and LasI in the presence of C4HSL.</p> |
| + | <p align="justify" class="info-18">Moreover, by co-culturing the cells containing this part with the cells containing 3OC12HSL dependent C4HSL producer part (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>), we succeeded in constructing a positive feedback system.</p> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td> | + | <td colspan="2"><div align="center"></div> |
| + | <div align="center"><img src="" height="400" /></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2">Informations</td> | + | <td colspan="2"><div align="center"> Fig. 5-1-2. </div> |
- | </tr>
| + | <div align="center"></div></td> |
- | <tr>
| + | |
- | <td colspan="2"> </td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><div align="center"><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></div></td>
| + | |
- | <td><div align="center"><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></div></td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td><div align="center"></div></td>
| + | |
- | <td><div align="center"></div></td>
| + | |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 224: |
Line 214: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="head">Best new BioBrick part (engineered): <a href="http://parts.igem.org/Part:BBa_K1139110" rel="nofollow">BBa_K</a></td> | + | <td colspan="2"><p class="head">Plux_CmR_RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td> | + | <td colspan="2"><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. <br /> |
| + | (CmR is Chloramphenicol resistance.) |
| + | </p> |
| + | <p class="info-18">This is the first Biobrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing luxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL.</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2">Informations</td> | + | <td colspan="2"><div align="center"></div> |
| + | <div align="center"><img src="" height="400" /></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td> | + | <td colspan="2"><div align="center"> Fig. 5-1-3. </div> |
| + | <div align="center"></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="entry-long"> </td> | + | <td> </td> |
| + | <td> </td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td> | + | <td colspan="2"><h2>Best Part Collection:<span class="head"> <a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>, <a href="http://parts.igem.org/Part:BBa_K1529263">BBa_K1529263</a><a href="http://parts.igem.org/Part:BBa_K1139201" rel="nofollow"></a></span> </h2></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"><span class="head" id="Best_Part_Collection">Best Part Collection</span></td> | + | <td colspan="2"><p class="head">Plux_CmR_LasI (<a href="http://parts.igem.org/Part:BBa_K1529263">BBa_K1529263</a>)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td> | + | <td colspan="2"><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0078">BBa_C0078</a>.<br /> |
| + | (CmR is Chloramphenicol resistance.)</p> |
| + | <p class="info-18">To characterize Plux-CmR-LasI (<a href="http://parts.igem.org/Part:BBa_K1529263">BBa_K1529263</a>), we introduced Plux-CmR-LasI on pSB3K3 with Ptet-RhlR-Ptet-GFP on pSB6A1 to E.coli as “C4HSL dependent CmR and 3OC12HSL producer cell”. In this E.coli, constitutively expressed RhlR activates the expression of CmR and LasI in the presence of C4HSL. </p> |
| + | <p class="info-18"> </p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2" class="underName"><a href="http://parts.igem.org/Part:BBa_K1139110" rel="nofollow">BBa_K</a>,<a href="http://parts.igem.org/Part:BBa_K1139110" rel="nofollow">BBa_K</a>,<a href="http://parts.igem.org/Part:BBa_K1139110" rel="nofollow">BBa_K</a>,<a href="http://parts.igem.org/Part:BBa_K1139110" rel="nofollow">BBa_K</a></td> | + | <td colspan="2"><div align="center"></div> |
| + | <div align="center"><img src="" height="400" /></div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td colspan="2"> </td>
| + | <td colspan="2"><div align="center"> Fig. 5-1-4. </div> |
- | </tr>
| + | <div align="center"></div></td> |
- | <tr>
| + | |
- | <td colspan="2">Informations</td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td colspan="2"> </td>
| + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td colspan="2"><div align="center"><img src="http://cyberd.org/img/3/Under-Construction-Anime.jpg" height="300" /></div></td> | + | |
- | </tr>
| + | |
- | <tr>
| + | |
- | <td colspan="2"> </td>
| + | |
| </tr> | | </tr> |
| </table> | | </table> |
- | | + | </div> |
- | | + | |
- |
| + | |
- | | + | |
- | </div> | + | |
| </div> | | </div> |
| </div> | | </div> |
Line 278: |
Line 263: |
| </div> | | </div> |
| <!-- end #page --> | | <!-- end #page --> |
| + | |
| | | |
| </div> | | </div> |